Innoviva, Inc. (INVA)

Healthcare · Biotechnology · NASDAQ

Innoviva, Inc. (INVA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.48B, a trailing price-to-earnings ratio of 10.9 and a free-cash-flow yield of 10.7%. Over the most recent reported fiscal year, revenue grew 14.7% and free cash flow per share fell 11.5%.

Market cap	$1.48B
Trailing P/E	10.9
FCF yield	10.7%
Revenue growth (YoY)	+14.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	-11.5%
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live INVA data on Nama Insights →

Recent Congressional trades

Innoviva, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
George Whitesides	House	Sell	$250,001 - $500,000	Mar 25, 2025